Mycobacterium genavense infection in normal and immunodeficient mice

Microbes and Infection

Volumn 2, Issue 6, 2000, Pages 575-580

  Matsiota Bernard, Peggy ^a   Vildé, Françoise ^b   Nauciel, Charles ^a  

^a Laboratoire de Microbiologie   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Mouse; Mycobacterium genavense

Indexed keywords

GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; FEMALE; GRANULOMA; HISTOPATHOLOGY; LIVER GRANULOMA; LUNG GRANULOMA; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM GENAVENSE; NONHUMAN; NUDE MOUSE; PATHOGENICITY; PRIORITY JOURNAL; SPLEEN DISEASE; T LYMPHOCYTE SUBPOPULATION;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS MUSCULUS; MYCOBACTERIUM GENAVENSE;

EID: 0034086185     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00369-5     Document Type: Article

References (23)

1. Hirschel B., Chang H.R., Mach N., Piguet P.F., Cox J., Piguet J.D., Silva M.T., Larssson L., Klatser P.R., Thole J.E.R., Rigouts L., Portaels F. Fatal infection with a novel unindentified mycobacterium in a man with the acquired immunodeficiency syndrome. New Engl. J. M. 340:1990;109-113.
2. Böttger E.C., Teske A., Kirschner P., Bost S., Chang H.R., Beer V., Hirschel B. Disseminated "Mycobacterium genavense" infection in patients with AIDS. Lancet. 13:1992;76-80.
3. Böttger E.C. Mycobacterium genavense: an emerging pathogen. Eur. J. Clin. Microbiol. Infect. Dis. 7:1994;932-936.
4. Bessesen M.T., Shlay J., Stone-Venohr B., Cohn D.L., Reves R.R. Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy. AIDS. 155:1993;1357-1361.
5. Pechère M., Opravril M., Wald A., Chave J.P., Bessesen M., Sievers A., Hein R., Von Overbeck J., Clark R.A., Tortoli E., Emler S., Kirschner P., Gabriel V., Böttger E.C., Hirschel B., the Swiss HIV Cohort Study. Clinical and epidemiologic features of infection with Mycobacterium genavense. Arch. Intern. M. 33:1995;400-404.
6. Dumonceau J.M., Fonteyne P.A., Realini L., Van Gossum A., Van Vooren J.P., Portaels F. Species-specific Mycobacterium genavense DNA in intestinal tissues of individuals not infected with human immunodeficiency virus. J. Clin. Microbiol. 24:1995;2514-2515.
7. Bogdan C., Kern P., Richter E., Tonnapfel A., Rusch-Gerdes S., Kirschner P., Solbach W. Systemic infection with Mycobacterium genavense following immunosuppressive therapy in a patient who was seronegative for human immunodeficiency virus. Clin. Infect. Dis. 31:1997;1245-1247.
8. Hoop R.K., Böttger E.C., Ossent P., Salfinger M. Mycobacteriosis due to Mycobacterium genavense in six pet birds. J. Clin. Microbiol. 34:1993;990-993.
9. Kiehn T.E., Hoefer H., Böttger E.C., Ross R., Wong M., Edwards F., Antinoff N., Armstrong D. Mycobacterium genavense infection in pet animals. J. Clin. Microbiol. 12:1996;1840-1842.
10. Schurr E., Malo D., Radzioch D., Buschman E., Morgan K., Gros P., Skamene E. Genetic control of innate resistance to mycobacterial infections. Immunol. Today. 73:1991;A42-A45.
11. Vidal S.M., Malo D., Vogan K., Skamene E., Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell. 182:1993;469-485.
12. Vidal S., Tremblay M.L., Govoni G., Gautier S., Sebastini G., Malo D., Skamene E., Olivier M., Jothy S., Gros P. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. M. 7:1995;655-666.
13. Cooper A.M., Flynn J.L. The protective immune response to Mycobacterium tuberculosis. Curr. Opin. Immunol. 60:1995;512-516.
14. Hubbard R.D., Flory C.M., Collins F.M. T-cell immune responses in Mycobacterium avium-infected mice. Infect. Immun. 25:1992;150-153.
15. Ladel C.H., Daugelat S., Kaufmann S.H.E. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol. 40:1995;377-384.
16. Potter M., O'Brien A.D., Skamene E., Gros P., Forget A., Kongshavn P.A.L., Wax J.S. A BALB/c congenic strain of mice that carries a genetic locus (ityr) controlling resistance to intracellular parasites. Infect. Immun. 145:1983;1234-1235.
17. Nauciel C. Role of CD4+ T cells and T-independent mechanisms in acquired resistance to Salmonella typhimurium infection. J. Immunol. 183:1990;1265-1269.
18. Medina E., North R.J. Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis. J. Exp. M. 62:1996;1045-1051.
19. Appelberg R., Castro A.G., Pedrosa J., Silva R.A., Orme I.M., Minoprio P. Role of gamma interferon and tumor necrosis factor alpha during T-cell independent and -dependent phases of Mycobacterium avium infection. Infect. Immun. 335:1994;3962-3971.
20. Newport M.J., Huxley C.M., Huston S., Hawrylowicz C.M., Oostra B.A., Williamson R., Levin M. A mutation in the interferon-γ -receptor gene and susceptibility to mycobacterial infection. New Engl. J. M. 335:1996;1941-1949.
21. Jouanguy E., Altare F., Lamhamedi S., Revy P., Emile J.F., Newport M., Levin M., Blanche S., Seboun E., Fischer A., Casanova J.L. Interferon γ receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. New Engl. J. M. 61:1996;1956-1961.
22. Bermudez L.E., Chapsi J. Infection with Mycobacterium avium induces production of interleukin-10 (IL-10) and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect. Immun. 151:1993;3093-3097.
23. Denis M., Ghadirian E. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J. Immunol. 1993;5425-5430.